These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 35099996)

  • 21. In patients hospitalized with COVID-19, therapeutic- vs. prophylactic-dose heparin did not reduce a composite outcome at 28 d.
    Bikdeli B; Garcia DA
    Ann Intern Med; 2022 Feb; 175(2):JC16. PubMed ID: 35099997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In high-risk inpatients with COVID-19, therapeutic- vs. standard-dose heparin reduced thromboembolism or death at 30 d.
    Bikdeli B; Garcia DA
    Ann Intern Med; 2022 Feb; 175(2):JC17. PubMed ID: 35099994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In non-critically ill patients with COVID-19, therapeutic anticoagulation improved survival to discharge without organ support.
    Donato AA
    Ann Intern Med; 2021 Dec; 174(12):JC134. PubMed ID: 34871053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation.
    Akl EA; Gunukula S; Barba M; Yosuico VE; van Doormaal FF; Kuipers S; Middeldorp S; Dickinson HO; Bryant A; Schünemann H
    Cochrane Database Syst Rev; 2011 Apr; (4):CD006652. PubMed ID: 21491396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation.
    Akl EA; Gunukula S; Barba M; Yosuico VE; van Doormaal FF; Kuipers S; Middeldorp S; Dickinson HO; Bryant A; Schünemann H
    Cochrane Database Syst Rev; 2011 Jan; (1):CD006652. PubMed ID: 21249680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: a systematic review with an updated meta-analysis.
    Duo H; Li Y; Sun Y; Wei L; Wang Z; Fang F; Zhong Y; Huang J; Luo L; Peng Z; Pan H
    Thromb J; 2022 Aug; 20(1):47. PubMed ID: 35999599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation.
    Akl EA; Kahale L; Terrenato I; Neumann I; Yosuico VE; Barba M; Sperati F; Schünemann H
    Cochrane Database Syst Rev; 2014 Jul; (7):CD006466. PubMed ID: 24980743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation.
    Akl EA; Kahale L; Terrenato I; Neumann I; Yosuico VE; Barba M; Sperati F; Schünemann H
    Cochrane Database Syst Rev; 2014 Jun; (6):CD006466. PubMed ID: 24897382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-molecular-weight heparin compared with unfractionated heparin in critically ill COVID-19 patients.
    Volteas P; Drakos P; Alkadaa LN; Cleri NA; Asencio AA; Oganov A; Giannopoulos S; Saadon JR; Mikell CB; Rubano JA; Labropoulos N; Tassiopoulos AK; Mofakham S; Bannazadeh M
    J Vasc Surg Venous Lymphat Disord; 2022 Sep; 10(5):1128-1136. PubMed ID: 35716998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three cases of spontaneous major bleeding in patients with a COVID-19 infection.
    Vos CG; Gravendeel J; Keller BPJA
    Acta Chir Belg; 2023 Feb; 123(1):72-75. PubMed ID: 33769205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysis.
    Zhang S; Li Y; Liu G; Su B
    Thromb J; 2021 Nov; 19(1):91. PubMed ID: 34819094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19.
    Vaughn VM; Yost M; Abshire C; Flanders SA; Paje D; Grant P; Kaatz S; Kim T; Barnes GD
    JAMA Netw Open; 2021 Jun; 4(6):e2111788. PubMed ID: 34115129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In suspected COVID-19, RT-PCR with nasal plus throat swabs has 97% sensitivity vs. nasopharyngeal swabs.
    Maki DG
    Ann Intern Med; 2021 Sep; 174(9):JC107. PubMed ID: 34487439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial.
    Barco S; Bingisser R; Colucci G; Frenk A; Gerber B; Held U; Mach F; Mazzolai L; Righini M; Rosemann T; Sebastian T; Spescha R; Stortecky S; Windecker S; Kucher N
    Trials; 2020 Sep; 21(1):770. PubMed ID: 32907635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation.
    Heidbuchel H; Verhamme P; Alings M; Antz M; Diener HC; Hacke W; Oldgren J; Sinnaeve P; Camm AJ; Kirchhof P
    Europace; 2015 Oct; 17(10):1467-507. PubMed ID: 26324838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19.
    Nadkarni GN; Lala A; Bagiella E; Chang HL; Moreno PR; Pujadas E; Arvind V; Bose S; Charney AW; Chen MD; Cordon-Cardo C; Dunn AS; Farkouh ME; Glicksberg BS; Kia A; Kohli-Seth R; Levin MA; Timsina P; Zhao S; Fayad ZA; Fuster V
    J Am Coll Cardiol; 2020 Oct; 76(16):1815-1826. PubMed ID: 32860872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Major bleeding complications in critically ill patients with COVID-19 pneumonia.
    Godier A; Clausse D; Meslin S; Bazine M; Lang E; Huche F; Cholley B; Hamada SR
    J Thromb Thrombolysis; 2021 Jul; 52(1):18-21. PubMed ID: 33646501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased incidence of massive hemorrhage at uncommon sites after initiation of systemic anticoagulation in critically ill patients with coronavirus disease 2019 (COVID-19) infection.
    Koubaissi SA; Daou MAZ; Mohamad R; Husari A
    J Thromb Thrombolysis; 2022 Jan; 53(1):231-234. PubMed ID: 34047936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticoagulation for perioperative thromboprophylaxis in people with cancer.
    Matar CF; Kahale LA; Hakoum MB; Tsolakian IG; Etxeandia-Ikobaltzeta I; Yosuico VE; Terrenato I; Sperati F; Barba M; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD009447. PubMed ID: 29993117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prothrombin complex concentrate versus placebo, no intervention, or other interventions in critically bleeding patients associated with oral anticoagulant administration: a protocol for a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis.
    Ovesen C; Purrucker J; Gluud C; Jakobsen JC; Christensen H; Steiner T
    Syst Rev; 2018 Oct; 7(1):169. PubMed ID: 30342540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.